ProQR Therapeutics reported a net margin of -99.65% for the quarter ended Jun 2026. These financial ratios cover 51 quarters of results from Sep 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2013 | Dec2013 | Mar2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||||||
| EBT Margin | -1,724.08% | -7,622.59% | -1,248.67% | -1,447.63% | -2,854.42% | -1,847.22% | -1,351.91% | -665.48% | -398.61% | -166.81% | -172.02% | -45.87% | -210.98% | -216.04% | -223.04% | -318.60% | -381.89% | -186.51% | -658.29% | -99.36% | |||||||||||||||||||||||||||||||
| EBIT Margin | -1,669.38% | -7,250.21% | -1,508.32% | -1,702.37% | -2,435.26% | -1,730.56% | -1,433.44% | -731.20% | -539.49% | -190.86% | -181.46% | -57.10% | -226.80% | -234.06% | -239.34% | -320.91% | -391.53% | -190.23% | -671.37% | -100.72% | |||||||||||||||||||||||||||||||
| EBITDA Margin | -1,669.38% | -7,250.21% | -1,508.32% | -1,702.37% | -2,435.26% | -1,730.56% | -1,433.44% | -731.20% | -539.49% | -190.86% | -181.46% | -57.10% | -226.80% | -234.06% | -239.34% | -320.91% | -391.53% | -190.23% | -671.37% | -100.72% | |||||||||||||||||||||||||||||||
| Operating Margin | -1,669.38% | -7,250.21% | -1,508.32% | -1,702.37% | -2,435.26% | -1,730.56% | -1,433.44% | -731.20% | -539.49% | -190.86% | -181.46% | -57.10% | -226.80% | -234.06% | -239.34% | -320.91% | -391.53% | -190.23% | -671.37% | -100.72% | |||||||||||||||||||||||||||||||
| Net Margin | -1,725.57% | -7,623.85% | -1,248.58% | -1,473.12% | -2,864.62% | -1,846.81% | -1,363.82% | -663.32% | -416.79% | -166.96% | -172.09% | -42.70% | -210.98% | -216.04% | -223.04% | -319.07% | -381.89% | -186.53% | -658.29% | -99.65% | |||||||||||||||||||||||||||||||
| FCF Margin | -903.90% | 1,677.82% | -1,789.65% | -1,571.29% | -1,857.25% | -2,478.61% | 6,849.01% | -834.27% | -523.28% | -143.73% | -323.60% | -94.99% | -139.76% | -213.95% | -344.63% | -296.04% | -418.67% | -268.32% | -540.14% | -136.76% | |||||||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 212.94M | 235.05M | 226.63M | 202.28M | 156.90M | 148.77M | 172.20M | 165.38M | 157.88M | 151.49M | 141.46M | 130.85M | 122.24M | 148.41M | 169.52M | 157.62M | 150.53M | 138.31M | 123.60M | 135.59M | |||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 173.74M | 180.98M | 164.08M | 143.38M | 75.29M | 72.39M | 69.96M | 63.15M | 56.14M | 49.15M | 42.57M | 40.16M | 32.39M | 99.53M | 87.93M | 81.17M | 72.33M | 63.14M | 49.81M | 98.21M | |||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.05 | 0.08 | 0.13 | 0.16 | 0.14 | 0.12 | 0.11 | 0.11 | 0.13 | 0.13 | 0.16 | |||||||||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -54.73 | 58.15 | 20.73 | -13.61 | -33.09 | 2.05 | 17.26 | -18.75 | -20.36 | 3.59 | -16.55 | -7.02 | -18.58 | 3.95 | -23.77 | -63.80 | -40.30 | 4.11 | -41.61 | ||||||||||||||||||||||||||||||||
| Debt Ratio | 0.10 | 0.21 | 0.24 | 0.25 | 0.05 | 0.02 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.04 | |||||||||||||||||||||||||||||||
| Times Interest Earned | -54.73 | 58.15 | 20.73 | -13.61 | -33.09 | 2.05 | 17.26 | -18.75 | -20.36 | 3.59 | -16.55 | -7.02 | -18.58 | 3.95 | -23.77 | -63.80 | -40.30 | 4.11 | -41.61 | ||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -25.53 | -27.40 | -4.05 | -3.80 | -2.24 | -22.04 | -17.95 | -15.04 | -16.90 | -27.30 | -22.39 | -46.58 | -16.63 | -22.94 | -10.80 | -12.74 | -14.25 | -20.50 | -10.89 | -19.32 | |||||||||||||||||||||||||||||||
| Price to SalesP/S | 440.60 | 0.00M | 50.59 | 56.03 | 64.28 | 407.07 | 244.85 | 99.78 | 70.45 | 45.59 | 38.54 | 19.89 | 35.08 | 49.57 | 24.09 | 40.65 | 54.42 | 38.23 | 71.71 | 19.25 | |||||||||||||||||||||||||||||||
| Price to BookP/B | 3.00 | 4.37 | 0.56 | 0.58 | 0.77 | 4.40 | 2.73 | 2.33 | 2.08 | 3.62 | 4.92 | 3.82 | 5.40 | 2.41 | 1.38 | 2.32 | 2.75 | 3.70 | 3.88 | 2.12 | |||||||||||||||||||||||||||||||
| Enterprise Value | 265.59M | 351.26M | -124.96M | -111.95M | -49.04M | 200.65M | 22.00M | -9.79M | -26.45M | 32.79M | 92.77M | 49.81M | 49.83M | 67.97M | -24.98M | 39.72M | 58.07M | 104.98M | 75.54M | 59.58M | |||||||||||||||||||||||||||||||
| EV to EBIT | -15.47 | -17.72 | 6.53 | 6.63 | 2.45 | -15.78 | -2.18 | 1.02 | 3.29 | -4.86 | -10.58 | -12.85 | -5.21 | -6.31 | 2.20 | -2.86 | -4.40 | -9.91 | -4.73 | -5.81 | |||||||||||||||||||||||||||||||
| EV to EBITDA | -15.47 | -17.72 | 6.53 | 6.63 | 2.45 | -15.78 | -2.18 | 1.02 | 3.29 | -4.86 | -10.58 | -12.85 | -5.21 | -6.31 | 2.20 | -2.86 | -4.40 | -9.91 | -4.73 | -5.81 | |||||||||||||||||||||||||||||||
| Market Capitalization | 453.08M | 571.04M | 64.16M | 55.61M | 52.76M | 299.02M | 172.14M | 130.92M | 105.06M | 161.08M | 186.30M | 135.05M | 148.07M | 228.13M | 114.50M | 175.62M | 183.36M | 212.83M | 170.68M | 195.97M | |||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -48.74 | 124.48 | -2.83 | -3.57 | -3.46 | -16.42 | 3.57 | -11.96 | -13.46 | -31.72 | -11.91 | -20.94 | -25.10 | -23.17 | -6.99 | -13.73 | -13.00 | -14.25 | -13.28 | -14.07 | |||||||||||||||||||||||||||||||
| EV to FCF | -28.57 | 76.57 | 5.51 | 7.18 | 3.22 | -11.02 | 0.46 | 0.89 | 3.39 | -6.46 | -5.93 | -7.72 | -8.45 | -6.90 | 1.53 | -3.11 | -4.12 | -7.03 | -5.88 | -4.28 | |||||||||||||||||||||||||||||||
| EV to CFO | -27.95 | 81.12 | 5.44 | 7.07 | 3.17 | -11.03 | 0.46 | 0.87 | 3.24 | -5.73 | -5.64 | -7.39 | -8.02 | -6.80 | 1.50 | -3.08 | -4.06 | -6.75 | -5.79 | -4.18 | |||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -1,669.38% | -7,250.21% | -1,508.32% | -1,702.37% | -2,435.26% | -1,730.56% | -1,433.44% | -731.20% | -539.49% | -190.86% | -181.46% | -57.10% | -226.80% | -234.06% | -239.34% | -320.91% | -391.53% | -190.23% | -671.37% | -100.72% | |||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -35.79% | -33.17% | -36.01% | -42.12% | -58.47% | -53.96% | -35.52% | -32.43% | -26.13% | -30.05% | -31.86% | -30.25% | -36.80% | -30.88% | -26.56% | -37.94% | -44.02% | -48.76% | -64.96% | -52.62% | |||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | -36.39% | -37.98% | -41.66% | -47.43% | -69.24% | -93.20% | -78.90% | -68.01% | -65.90% | -72.31% | -66.83% | -80.51% | -49.68% | -53.64% | -63.51% | -71.77% | -67.57% | ||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -31.66% | -30.87% | -32.29% | -33.95% | -47.38% | -45.24% | -35.41% | -33.50% | -24.04% | -19.86% | -20.42% | -17.92% | -21.64% | -20.26% | -19.09% | -27.14% | -31.05% | -34.44% | -42.64% | -36.17% |